MIRA
INFORM REPORT
|
Report Date : |
16.01.2007 |
IDENTIFICATION
DETAILS
|
Name : |
SCANDITRONIX WELLHÖFER AB |
|
|
|
|
Registered Office : |
Stålgatan 14, 754 50 Uppsala |
|
|
|
|
Country : |
Sweden
|
|
|
|
|
Financials (as on) : |
31.12.2005 |
|
|
|
|
Date of Incorporation : |
1994 |
|
|
|
|
Com. Reg. No.: |
556502-2984 |
|
|
|
|
Legal Form : |
Limited
Company, Private |
|
|
|
|
Line of Business : |
Manufacture
of instruments |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal.
Capable to meet normal commitments. |
Satisfactory |
|
Maximum Credit Limit : |
3.000 TSEK |
|
|
|
|
Status : |
Satisfactory
|
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
|
Scanditronix
Wellhöfer AB |
Company no |
556502-2984 |
|
Stålgatan 14 |
Telephone |
+46-18-18 07 00 |
|
754 50 Uppsala |
|
|
|
Visiting address Stålgatan 14 |
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Debt with the Enforcement Service
No debt registered with the Swedish Enforcement Authority as at
2007-01-12.
Group of companies
Part of Mediflash Holding AB-group
Note: Share capital has decreased substantially since the last annual
report.
Note: Change of auditor occurred 060919.
Note: Notification of a change in the board of directors has been
submitted to the Registration Office due to relocation etc.
|
New auditor |
2006-09-19 |
|
Pet. for inj. to
pay |
2006-06 |
Credit opinion
Industry
Risk Forecast: 0,4 %
Median
value for limited company in industry 33200, such as Manufact of instruments
and appl for measuring, checking etc.
Other
information may of course affect your assessment of the risk
Credit
limit: 3.000 TSEK
Applies
to short-term credit facilities. The limit has been set using a formula that
takes into consideration the annual accounts included in this credit report and
the current credit rating. Other information may of course influence the size
of the credit you may grant.
General
information and history
|
Legal form |
Limited company, private |
|
Vat-number |
SE 556502298401 |
|
Registered office |
Uppsala municipality
in Uppsala county |
|
Number of locations |
1 |
|
Main establishment |
|
|
Name |
Head office |
|
Visiting address |
Stålgatan
14, 754 50 Uppsala |
|
Description of business
activities |
|
|
Manufacture of instruments and
appl for measuring, checking etc. |
|
|
(Main business according to
Statistics Sweden, SNI2002: 33200) |
|
|
|
|
|
Manufact of medical &
surgical equipm, ortopaedic appl, not dental |
|
|
(Subsidiary business according
to Statistics Sweden, SNI2002: 33101) |
|
|
|
|
|
History |
|
|
|
|
|
1994-12 |
Comp reg under the current reg
no and name: Scanditronix Medical AB |
|
1995-01 |
Company registered to pay
business tax |
|
1995-01 |
Company registered to pay VAT |
|
1995-01 |
Company registered to pay
employer contributions |
|
1995-04 |
Operations taken over from
Scanditronix AB (556098-7181) |
|
2003-04 |
Taken over Scanditronix
Ophthalmology AB through merger |
|
2003-04 |
Company reg under the current
name |
|
2004-10 |
Johannes Robby Maria Plompen
new Managing Director |
|
2005-08 |
Articles of Association adopted |
|
Matters pending with
Registration Office |
Reg date |
Jour no |
|
|
|
|
|
Change of board/auditors due to
emigration etc |
2006-11-24 |
35375306 |
Non
categorized information
Customs
have granted the company to bring home goods/credit permit
Link
to homepage
Note: Note that the company took over
Scanditronix Ophthalmology AB through merger in 03-04.
Board
members according to Reg Office
Board
members etc reg prior to 1991-04 unless otherwise stated.
Board
member company commitments is displayed when the name is clicked.
|
Johannes Robby Maria Plompen, Birth:1963 |
MD and Regular member |
Reg. in company 2004-07-02 |
|
|
|
Reg MD 2004-10-25 |
|
|
|
Living abroad |
|
Erik Jöreskog, Birth:1963 |
Dep. MD and Regular member |
Reg. in company 2004-07-02 |
|
|
|
Emigrated |
|
|
|
Living abroad |
|
ierre Marie Fernand Ghislain
Mottet,
Birth:1961 |
Regular member |
Reg. in company 2002-04-08 |
|
|
|
Living abroad |
|
Xavier Anne Jean-Louis Defourt, Birth:1968 |
Regular member |
Reg. in company 2003-11-04 |
|
|
|
Living abroad |
|
Ernst & Young AB |
Revisionsföretag |
Reg. in company 2006-09-19 |
|
|
||
Board
of directors data
|
No of board members (ord
members and MD) |
4 |
|
|
Any board member with comm in
other comp? |
Yes |
|
|
Any board member with comm in
bankrupt comp? |
No |
|
|
Any board member with payment
complaint? |
No |
|
|
Any board member with
bankruptcy petition? |
No |
|
|
Any board member with bal of
debt with Enf Auth? |
No |
|
|
Authorized signatory (available
in Swedish only) |
|
Firman tecknas av styrelsen |
|
firman tecknas två i förening
av |
|
-Ledamöterna |
|
Dessutom har
verkställande direktören rätt att teckna firman |
|
beträffande löpande
förvaltningsåtgärder |
|
|
Note: Change of auditor occurred
060919.
Note: Notification of a change in the
board of directors has been submitted to the Registration Office due to
relocation etc.
Group relationship
etc
|
Parent company etc |
Proprietary
int |
As of |
Comments |
|
Mediflash Holding AB,
556514-5553 |
100 % |
2006-06 |
Cr. rating: undecided |
|
Shareholder in parent company |
Ownership |
As of |
Comments |
|
Ion Beam Applications SA,
Belgium |
100 % |
2006-06 |
|
|
|
|||
For a complete specification of subsidiaries etc, see
enclosure
|
Annual accounts |
|
||||
|
Inc. statement in TSEK |
0501-0512 |
0401-0412 |
0301-0312 |
0201-0212 |
0101-0112 |
|
Net sales |
+87.691 |
+155.546 |
+71.423 |
+68.878 |
+60.345 |
|
Personnel costs |
-22.381 |
-26.367 |
-34.050 |
-37.964 |
-43.330 |
|
Profit/loss after financial
items |
+290.363 |
-46.113 |
-204.313 |
-284.422 |
+240.909 |
|
Balance sheet in TSEK |
0501-0512 |
0401-0412 |
0301-0312 |
0201-0212 |
0101-0112 |
|
Total fixed assets |
1.674.655 |
1.443.489 |
1.488.230 |
1.618.379 |
1.902.115 |
|
Total current assets |
102.078 |
78.823 |
76.036 |
132.246 |
170.303 |
|
Total equity |
1.758.388 |
1.468.029 |
1.509.137 |
1.709.635 |
1.880.030 |
|
Total long-term liabilities |
0 |
0 |
0 |
100 |
25.666 |
|
Total current liabilities |
17.521 |
53.456 |
53.358 |
38.882 |
51.820 |
|
Total equity and liabilities |
1.776.733 |
1.522.312 |
1.564.266 |
1.750.625 |
2.072.418 |
|
Notes etc |
0501-0512 |
0401-0412 |
0301-0312 |
0201-0212 |
0101-0112 |
|
Employees |
34 |
48 |
48 |
65 |
74 |
|
Audit report |
Unqualified |
Unqualified |
Unqualified |
Unqualified |
Unqualified |
|
Ratios |
||||||
|
Ratios 1) |
|
0501-0512 |
0401-0412 |
0301-0312 |
0201-0212 |
0101-0112 |
|
Equity/assets % |
39,6 1) |
99,0 |
96,4 |
96,5 |
97,6 |
94,6 |
|
Consolidation Ratio % |
45,6 1) |
99,0 |
96,4 |
96,5 |
97,6 |
96,3 |
|
Quick ratio % |
130,8
1) |
452,2 |
107,5 |
106,0 |
245,8 |
244,5 |
|
Return on total assets % |
13,0 1) |
16,3 |
0,5 |
0,0 |
2,0 |
11,7 |
|
Cash Flow/Total liabilities % |
25,2 1) |
>999,9 |
-79,3 |
-367,0 |
-695,8 |
248,6 |
|
Risk margin % |
11,9 1) |
16,0 |
-98,9 |
-371,7 |
-778,9 |
10,4 |
1) Values
for the industry in 2005 = Median for companies with at
least 20 employees in industry 33200 i.e. Manufact of
instruments and appl for measuring, checking etc
Note: the forecast for the company's
insolvency is low.
For the complete annual accounts and all ratios, see
enclosure
|
Share capital |
|
|
|
Total |
375.673 TSEK |
|
The most
recently registered changes in the share capital
|
2005-08 |
-1.245.000 TSEK |
|
Reduction |
|
|
1999-04 |
1.614.790 TSEK |
|
New issue |
|
|
1995-01 |
5.833 TSEK |
|
New issue |
|
Chattel
mortgages
|
Total |
30.000,0
TSEK |
|
The most
recently issued mortgages
|
2000-03 |
15.000,0 TSEK |
|
|
1995-08 |
15.000,0 TSEK |
|
Unprivileged
claims in clients´ bankruptcies
We has
not been notified about any unprivileged claims in bankruptcies in the last 2
years.
Properties
We has
not been notified about any property ownership.
Note: Share capital has decreased
substantially since the last annual report.
Payment
complaints, complaints and other payment information
No
complaints have been registered.
1 claim
totalling 7,0 TSEK has been registered.
|
Claims |
|
Amount
SEK |
|
Creditor |
|
Pet. for inj. to pay |
2006-06 |
6.964 |
|
Age Kontor & Data AB |
No debt
registered with the Swedish Enforcement Authority as at 2007-01-12.
The
company has not had any debt registered with the Swedish Enforcement Authority
either in the last 24 months.
Annual accounts and ratios
|
Annual accounts |
||||||
|
Inc. statement in TSEK |
0501-0512 |
0401-0412 |
0301-0312 |
0201-0212 |
0101-0112 |
|
|
Net sales |
+87.691 |
+155.546 |
+71.423 |
+68.878 |
+60.345 |
|
|
Change in inventories of prod
etc |
+2.773 |
-80.629 |
+25.160 |
+15.915 |
+67.500 |
|
|
Other operating income |
+6.412 |
+3.273 |
+1.230 |
+2.163 |
+2.632 |
|
|
Raw materials/consumables |
-38.165 |
-33.703 |
-32.423 |
-35.505 |
-53.811 |
|
|
Other external costs |
-17.429 |
-9.901 |
-35.905 |
-41.142 |
-42.822 |
|
|
Personnel costs |
-22.381 |
-26.367 |
-34.050 |
-37.964 |
-43.330 |
|
|
Depreciation |
-537 |
-760 |
-964 |
-3.277 |
-1.850 |
|
|
Items affecting comparability |
0 |
0 |
0 |
-24.149 |
0 |
|
|
Other operating expenses |
0 |
-17 |
-1 |
-610 |
0 |
|
|
Operating profit/loss |
+18.364 |
+7.442 |
-5.530 |
-55.691 |
-11.336 |
|
|
|
||||||
|
Result from participations in
group and associated companies |
+14.712 |
0 |
+5.430 |
0 |
+148.766 |
|
|
Interest income group companies |
0 |
0 |
0 |
+89.517 |
+96.677 |
|
|
External interest income |
+660 |
+407 |
+715 |
+1.120 |
+1.792 |
|
|
Other financial income |
+256.687 |
0 |
0 |
+725 |
+6.414 |
|
|
Total financial income |
+272.059 |
+407 |
+6.145 |
+91.362 |
+253.649 |
|
|
Interest expense to group
companies |
0 |
0 |
0 |
-313.546 |
0 |
|
|
External interest expenses |
-60 |
-162 |
-247 |
-702 |
-1.376 |
|
|
Other financial expenses |
0 |
-53.800 |
-204.681 |
-5.845 |
-28 |
|
|
Total financial expenses |
-60 |
-53.962 |
-204.928 |
-320.093 |
-1.404 |
|
|
Profit/loss after financial
items |
+290.363 |
-46.113 |
-204.313 |
-284.422 |
+240.909 |
|
|
|
||||||
|
Profit/loss before
appropriations |
+290.363 |
-46.113 |
-204.313 |
-284.422 |
+240.909 |
|
|
Appropriations |
0 |
0 |
0 |
+114.903 |
-58.987 |
|
|
Profit/loss before tax |
+290.363 |
-46.113 |
-204.313 |
-169.519 |
+181.922 |
|
|
Tax |
-4 |
+2.292 |
+1.040 |
-4.075 |
-50.156 |
|
|
Net profit/loss for the year |
+290.359 |
-43.821 |
-203.273 |
-173.594 |
+131.766 |
|
|
Balance sheet in TSEK |
0501-0512 |
0401-0412 |
0301-0312 |
0201-0212 |
0101-0112 |
|
|
Concessions, patents, licences,
trademarks and similar rights |
0 |
0 |
0 |
0 |
1.378 |
|
|
Total intangible assets |
0 |
0 |
0 |
0 |
1.378 |
|
|
Equipment |
596 |
942 |
1.364 |
0 |
0 |
|
|
Total machinery and equipment |
596 |
942 |
1.364 |
1.679 |
3.341 |
|
|
Total tangible assets |
596 |
942 |
1.364 |
1.679 |
3.341 |
|
|
Participations in group and
associated companies |
28.221 |
28.336 |
28.336 |
26.336 |
28.221 |
|
|
Receivables from group and
associated companies |
1.645.838 |
1.414.211 |
1.458.530 |
1.588.364 |
1.869.175 |
|
|
Other financial assets |
0 |
0 |
0 |
2.000 |
0 |
|
|
Total financial assets |
1.674.059 |
1.442.547 |
1.486.866 |
1.616.700 |
1.897.396 |
|
|
Total fixed assets |
1.674.655 |
1.443.489 |
1.488.230 |
1.618.379 |
1.902.115 |
|
|
|
||||||
|
Work in progress on contract |
15.664 |
13.142 |
9.920 |
0 |
19.096 |
|
|
Other inventories |
7.177 |
8.212 |
9.572 |
36.661 |
24.516 |
|
|
Total inventories |
22.841 |
21.354 |
19.492 |
36.661 |
43.612 |
|
|
Accounts receivable |
9.026 |
5.152 |
11.807 |
3.687 |
14.589 |
|
|
Receivables from group and
associated companies |
5.956 |
5.250 |
12.628 |
9.670 |
0 |
|
|
Other current receivables |
2.477 |
2.017 |
4.400 |
9.079 |
8.104 |
|
|
Total current receivables |
17.459 |
12.419 |
28.835 |
22.436 |
22.693 |
|
|
Total cash and bank balances |
61.778 |
45.050 |
27.709 |
73.149 |
103.998 |
|
|
Total current assets |
102.078 |
78.823 |
76.036 |
132.246 |
170.303 |
|
|
|
||||||
|
Total assets |
1.776.733 |
1.522.312 |
1.564.266 |
1.750.625 |
2.072.418 |
|
|
Balance sheet in TSEK |
0501-0512 |
0401-0412 |
0301-0312 |
0201-0212 |
0101-0112 |
|
|
Share capital |
1.620.673 |
1.620.673 |
1.620.673 |
1.620.673 |
1.620.673 |
|
|
Other restricted equity |
14.810 |
14.810 |
14.810 |
14.810 |
14.810 |
|
|
Profit/loss brought forward |
-167.454 |
-123.633 |
76.927 |
247.746 |
112.781 |
|
|
Net profit/loss for the year |
290.359 |
-43.821 |
-203.273 |
-173.594 |
131.766 |
|
|
Total equity |
1.758.388 |
1.468.029 |
1.509.137 |
1.709.635 |
1.880.030 |
|
|
|
||||||
|
Total untaxed reserves |
0 |
0 |
0 |
0 |
114.902 |
|
|
Total provisions |
824 |
827 |
1.772 |
2.008 |
0 |
|
|
Liabilities to credit
institutions |
0 |
0 |
0 |
0 |
25.566 |
|
|
Utilised overdraft facilities |
|
|
|
0 |
24.841 |
|
|
Liabilities to group and
associated companies |
0 |
0 |
0 |
100 |
100 |
|
|
Total long-term liabilities |
0 |
0 |
0 |
100 |
25.666 |
|
|
|
||||||
|
Accounts payable |
2.491 |
2.775 |
12.214 |
6.024 |
9.011 |
|
|
Liabilities to group and
associated companies |
126 |
19.178 |
17.922 |
0 |
4.247 |
|
|
Other current liabilities |
14.904 |
31.503 |
23.222 |
32.858 |
38.562 |
|
|
Total current liabilities |
17.521 |
53.456 |
53.358 |
38.882 |
51.820 |
|
|
|
||||||
|
Total equity and liabilities |
1.776.733 |
1.522.312 |
1.564.266 |
1.750.625 |
2.072.418 |
|
|
Notes etc in TSEK |
0501-0512 |
0401-0412 |
0301-0312 |
0201-0212 |
0101-0112 |
|
Employees |
34 |
48 |
48 |
65 |
74 |
|
Salaries board/MD |
0 |
0 |
1.671 |
1.226 |
1.349 |
|
Salaries others |
14.937 |
17.261 |
22.074 |
24.145 |
27.520 |
|
Total salaries |
14.937 |
17.261 |
23.745 |
25.371 |
28.869 |
|
Total salaries and remuneration |
14.937 |
17.261 |
23.745 |
25.371 |
28.869 |
|
Social security expenses |
6.338 |
7.710 |
9.321 |
11.313 |
12.222 |
|
Dividend |
70.000 |
0 |
0 |
0 |
0 |
|
Contractual severance pay |
No |
No |
No |
No |
No |
|
Total depreciation |
537 |
760 |
964 |
3.277 |
1.850 |
|
Bank overdraft facilities
granted |
|
|
|
39.000 |
39.000 |
|
Utilised overdraft facilities |
|
|
|
0 |
24.841 |
|
Floating charges |
30.000 |
30.000 |
30.000 |
30.000 |
30.000 |
|
Other pledges |
232 |
228 |
224 |
0 |
0 |
|
Total pledged assets |
30.232 |
30.228 |
30.224 |
30.000 |
30.000 |
|
Other contingent liabilities |
0 |
0 |
482 |
0 |
0 |
|
Total contingent liabilities |
0 |
0 |
482 |
0 |
0 |
|
Audit report |
0501-0512 |
0401-0412 |
0301-0312 |
0201-0212 |
0101-0112 |
|
Audit report |
Unqualified |
Unqualified |
Unqualified |
Unqualified |
Unqualified |
|
Original annual account |
|||||
|
Order by additional choice |
Yes |
Yes |
Yes |
Yes |
Yes |
|
Ratios 1) |
||||||
|
Profitability |
|
0501-0512 |
0401-0412 |
0301-0312 |
0201-0212 |
0101-0112 |
|
Return on equity % |
33,0 1) |
16,5 |
-3,1 |
-13,5 |
-16,6 |
12,3 |
|
Return on total assets % |
13,0 1) |
16,3 |
0,5 |
0,0 |
2,0 |
11,7 |
|
Average interest rate % |
-1,2 1) |
-0,3 |
-99,4 |
-371,7 |
-780,9 |
-1,2 |
|
Risk margin % |
11,9 1) |
16,0 |
-98,9 |
-371,7 |
-778,9 |
10,4 |
|
Gross margin % |
10,2 1) |
20,1 |
5,2 |
-6,3 |
-73,8 |
-15,1 |
|
Operating margin % |
7,6 1) |
19,5 |
4,7 |
-7,6 |
-78,4 |
-18,0 |
|
Net margin % |
9,1 1) |
308,6 |
-29,0 |
-281,2 |
-400,4 |
382,5 |
|
Interest cover |
15,4 1) |
>999,9 |
0,2 |
0,0 |
0,1 |
172,6 |
|
Capital circulation |
||||||
|
Capital turnover rate |
1,6 1) |
0,0 |
0,1 |
0,0 |
0,0 |
0,0 |
|
Cash Flow/Total liabilities % |
25,2 1) |
>999,9 |
-79,3 |
-367,0 |
-695,8 |
248,6 |
|
Cash fl/finexp % |
1.832,2
1) |
>999,9 |
-79,8 |
-98,7 |
-89,1 |
>999,9 |
|
Self-financing ratio % |
245,7
1) |
125,8 |
- |
- |
- |
- |
|
Stock turnover/year |
6,6 1) |
4,1 |
7,4 |
3,7 |
1,9 |
1,4 |
|
Turnover/employee TSEK |
1.839,0
1) |
2.767,0 |
3.308,0 |
1.513,0 |
1.092,0 |
851,0 |
|
Lab costs/turnover % |
-18,7
1) |
-15,9 |
-10,9 |
-32,7 |
-35,7 |
-45,8 |
|
Working capital/turn % |
20,5 1) |
89,8 |
16,0 |
31,2 |
131,4 |
188,1 |
|
Acc rec/turnover % |
13,0 1) |
9,6 |
3,2 |
16,2 |
5,2 |
23,2 |
|
Stock/turnover % |
15,2 1) |
24,3 |
13,4 |
26,8 |
51,6 |
69,2 |
|
Short liabilities/turnover % |
23,6 1) |
18,6 |
33,6 |
73,4 |
54,7 |
82,3 |
|
Customer credit time |
49,4 1) |
18,8 |
13,3 |
26,6 |
32,2 |
- |
|
Credit period granted |
22,6 1) |
7,0 |
11,8 |
31,4 |
26,4 |
- |
|
Liquidity |
||||||
|
Current ratio % |
196,8
1) |
582,6 |
147,4 |
142,5 |
340,1 |
328,6 |
|
Quick ratio % |
130,8
1) |
452,2 |
107,5 |
106,0 |
245,8 |
244,5 |
|
Consolidation |
||||||
|
Equity/assets % |
39,6 1) |
99,0 |
96,4 |
96,5 |
97,6 |
94,6 |
|
Consolidation Ratio % |
45,6 1) |
99,0 |
96,4 |
96,5 |
97,6 |
96,3 |
|
Debt/equity ratio |
1,5 1) |
0,0 |
0,0 |
0,0 |
0,0 |
0,1 |
|
Risk ratio |
4,4 1) |
- |
- |
0,0 |
- |
- |
|
Fixed assets structure |
||||||
|
Financial assets structure % |
24,8 1) |
100,0 |
99,9 |
99,9 |
99,9 |
99,8 |
|
Intangible assets structure % |
6,1 1) |
- |
- |
- |
- |
0,1 |
|
Tangible assets structure % |
63,7 1) |
0,0 |
0,1 |
0,1 |
0,1 |
0,2 |
1) Values for the industry
in 2005 = Median for companies with at least
20 employees in industry 33200 i.e. Manufact of instruments
and appl for measuring, checking etc
Analysis
of the annual accounts (three years)
Turnover/Capital
employed
Turnover
fell very steeply in 2005. This may indicate that the companies have completely
changed their operations. If this is the case then events etc. which have
occurred previously may be irrelevant.
Financing
Recent
investments in fixed assets have been financed exclusively by means of
increased indebtedness.
Turnover
is falling while the stocks are increasing. There may be a risk that the
company has stocks which, apart from tying up capital, may also be difficult to
sell.
Note: the forecast for the company's
insolvency is low.
Group relationship
|
Parent company etc |
Proprietary
int |
As of |
Comments |
|
Mediflash Holding AB,
556514-5553 |
100 % |
2006-06 |
Cr. rating: undecided |
|
Shareholder in parent company |
Ownership |
As of |
Comments |
|
Ion Beam Applications SA,
Belgium |
100 % |
2006-06 |
|
|
Subsidiary,*sub-subsidiary etc |
Ownership |
As of |
Comments |
|
Iba Advanced Radiotherapy AB,
556295-9626 |
100 % |
2006-06 |
Inactive |
|
|
|||
|
Scanditronix Wellhöfer GmbH,
Germany |
100 % |
2006-06 |
|
|
Former parent companies etc |
Ownership |
Comments |
|
Vencap Industrier AB,
556438-2595 |
100 % |
Parent company until 94/95 |
|
|
||
|
Vencap Industrier AB,
556438-2595 |
100 % |
Parent company until 95-06 |
|
Former subsidiaries etc |
Ownership |
Comments |
|
Scanditronix Medical Vertriebs
GmbH, Germany |
100 % |
Deregistered during 04 due to
merger |
|
|
Former subsidiary |
|
|
Wellhöfer Dosimetric GmbH,
Germany |
100 % |
Sold during 04 |
|
|
Former subsidiary |
|
|
Iba Kft, Hungary |
96 % |
Sold during 05 |
|
|
Former subsidiary |
|
|
Scanditronix Ophthalmology AB,
556273-4441 |
100 % |
Deregistered 03-07 due to
merger Former subsidiary |
|
Scanditronix Magnet AB,
556224-6107 |
100 % |
Sold 05-12 within the group |
|
|
Former subsidiary |
|
|
Scanditronix Magnet AB,
556224-6107 |
100 % |
Sold 95-06 |
|
|
Former subsidiary |
|
|
Scandiflash AB, 556233-2154 |
100 % |
Sold 95-06 |
|
|
Former subsidiary |
|
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial
base with the strongest capability for timely payment of interest and
principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No
caution needed for credit transaction. It has above average (strong)
capability for payment of interest and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are
regarded healthy. General unfavourable factors will not cause fatal effect.
Satisfactory capability for payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal.
Capable to meet normal commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors
carry similar weight in credit consideration. Capability to overcome
financial difficulties seems comparatively below average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of
interest and principal sums in default or expected to be in default upon
maturity |
Limited with full security |
|
<10 |
C |
Absolute credit risk exists. Caution
needed to be exercised |
Credit not recommended |
|
NR |
In view of the lack of information, we have
no basis upon which to recommend credit dealings |
No Rating |
|